Table 1.
The characteristics of the patients at baseline.
| Characteristics | Entire group: 95 patients | ||
|---|---|---|---|
| TMZ 6-cycle, 46 patients n (%) |
TMZ 12-cycle, 49 patients n (%) |
P value | |
| Male Gender | 37(80.4) | 28 (57.1) | 0.015 |
| Age > 45 | 22 (47.8) | 25 (51) | 0.75 |
|
Karnofsky
Performance Status ≥ 80% |
32 (69.5) | 31 (63.2) | 0.43 |
| Focal neurological deficits | 16 (34.8) | 18 (36.7) | 0.83 |
|
Tumor resection:
Gross total Subtotal Biopsy only |
8 (17.4) 28 (60.9) 10 (21.7) |
9 (18.4) 24 (49) 16 (32.7) |
0.43 |
|
Histology:
Glioblastoma Anaplastic astrocytoma |
37 (80.4) 9 (19.6) |
40 (81.6) 9 (18.4) |
0.82 |
YMZ: temozolomide.